Latest News

Date Title Topic
19 Dec 2016 ESMO Patient Guides in Liver and Bladder Cancers
19 Dec 2016 EMA Recommends to Extend Indications for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
Webcasts
18 Dec 2016 ESMO Asia 2016 Press Release: Immunotherapy with Pembrolizumab Deemed Cost-Effective for Advanced Melanoma Patients in Hong Kong Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
18 Dec 2016 ESMO Asia 2016 Press Release: Routine Blood Test Predicts How Long Cancer Patients Will Survive Palliative and supportive care
18 Dec 2016 ESMO Asia 2016 Press Release: Cancer Costs Leaving Patients in Debt Bioethics, legal and economic issues
18 Dec 2016 ESMO Asia 2016 Press Release: Depressed Patients Are Less Responsive to Chemotherapy Anticancer agents & Biologic therapy
18 Dec 2016 ESMO Asia 2016 Press Release: Anxiety and Depression a Major Issue for Cancer Survivors
18 Dec 2016 ESMO Asia 2016 Press Release: Ribociclib Improves Progression-free Survival in Asian Women with Advanced Breast Cancer Breast cancer
Photo Reportage
17 Dec 2016 ESMO Asia 2016 Press Release: First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore Sarcomas
16 Dec 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Alectinib for the Treatment of ALK-Positive Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Dec 2016 ESMO Asia 2016 Media Alert: ESMO Asia Congress to Return to Singapore for the 2nd Time
16 Dec 2016 ESMO Asia 2016 Press Release: Asian Head and Neck Cancer Patients Live Longer with Immunotherapy than Mixed Race Group Head and neck cancers
15 Dec 2016 EMA Hosts Workshop on Adaptive Pathways Bioethics, legal and economic issues